Article
Role of genetic testing in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Clinical genetics - 1 Jan 2010
Barahona-Dussault C, Benito B, Campuzano O, Iglesias A, Leung T L, Robb L, Talajic M, Brugada R
Abstract excerpt
In a cohort of patients with confirmed or suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D), genetic testing is useful in confirming the diagnosis, particularly in individuals who do not completely fulfil Task Force criteria for the disease, thereby also enabling the adoption of preventive measures in family members. Due to the high percentage of novel mutations that are expected to be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
